157 related articles for article (PubMed ID: 31428634)
1. Technical Verification and Assessment of Independent Validation of Biomarker Models for Endometriosis.
O DF; Fassbender A; Van Bree R; Laenen A; Peterse DP; Vanhie A; Waelkens E; D'Hooghe TM
Biomed Res Int; 2019; 2019():3673060. PubMed ID: 31428634
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a panel of 28 biomarkers for the non-invasive diagnosis of endometriosis.
Vodolazkaia A; El-Aalamat Y; Popovic D; Mihalyi A; Bossuyt X; Kyama CM; Fassbender A; Bokor A; Schols D; Huskens D; Meuleman C; Peeraer K; Tomassetti C; Gevaert O; Waelkens E; Kasran A; De Moor B; D'Hooghe TM
Hum Reprod; 2012 Sep; 27(9):2698-711. PubMed ID: 22736326
[TBL] [Abstract][Full Text] [Related]
3. Use of serum-soluble intercellular adhesion molecule-1 as a new marker of endometriosis.
Somigliana E; Viganò P; Candiani M; Felicetta I; Di Blasio AM; Vignali M
Fertil Steril; 2002 May; 77(5):1028-31. PubMed ID: 12009362
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of new biomarkers in stage III and IV endometriosis.
Kovalak EE; Karacan T; Zengi O; Karabay Akgül Ö; Özyürek ŞE; Güraslan H
Gynecol Endocrinol; 2023 Dec; 39(1):2217290. PubMed ID: 37236244
[TBL] [Abstract][Full Text] [Related]
5. [Serum levels of soluble intercellular molecule 1 (sICAM-1) in endometriosis].
Leng J; Lang J; Zhao D; Liu D
Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):189-90. PubMed ID: 11953158
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6, intracellular adhesion molecule-1, and glycodelin A levels in serum and peritoneal fluid as biomarkers for endometriosis.
Mosbah A; Nabiel Y; Khashaba E
Int J Gynaecol Obstet; 2016 Sep; 134(3):247-51. PubMed ID: 27236647
[TBL] [Abstract][Full Text] [Related]
7. Concentration of soluble intercellular adhesion molecule-1 in serum samples from patients with endometriosis collected during the luteal phase of the menstrual cycle.
Steff AM; Gagné D; Pagé M; Hugo P; Gosselin D
Hum Reprod; 2004 Jan; 19(1):172-8. PubMed ID: 14688178
[TBL] [Abstract][Full Text] [Related]
8. Serum markers for the noninvasive diagnosis of endometriosis.
Luisi S; Pinzauti S; Regini C; Petraglia F
Womens Health (Lond); 2015 Aug; 11(5):603-10. PubMed ID: 26395072
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive diagnosis of endometriosis: Review of current peripheral blood and endometrial biomarkers.
O DF; Flores I; Waelkens E; D'Hooghe T
Best Pract Res Clin Obstet Gynaecol; 2018 Jul; 50():72-83. PubMed ID: 29778458
[TBL] [Abstract][Full Text] [Related]
10. Models including serum CA-125, BMI, cyst pathology, dysmenorrhea or dyspareunia for diagnosis of endometriosis.
Knific T; Vouk K; Vogler A; Osredkar J; Gstöttner M; Wenzl R; Rižner TL
Biomark Med; 2018 Jul; 12(7):737-747. PubMed ID: 29865858
[TBL] [Abstract][Full Text] [Related]
11. Serum prolactin and CA-125 levels as biomarkers of peritoneal endometriosis.
Bilibio JP; Souza CA; Rodini GP; Andreoli CG; Genro VK; de Conto E; Cunha-Filho JS
Gynecol Obstet Invest; 2014; 78(1):45-52. PubMed ID: 24861131
[TBL] [Abstract][Full Text] [Related]
12. Identification of Serum Biomarkers for Diagnosis of Endometriosis Using Multiplex Immunoassays.
Kim H; Choi YS; Kim JS; Kim S; Won BH; Won YB; Lee I; Lee JH; Yun BH; Seo SK; Park JH; Cho S; Shin JH; Lim JB; Lee BS
Reprod Sci; 2020 May; 27(5):1139-1147. PubMed ID: 32046464
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive diagnosis of moderate to severe endometriosis: the platelet-lymphocyte ratio cannot be a neoadjuvant biomarker for serum cancer antigen 125.
Yang H; Zhu L; Wang S; Lang J; Xu T
J Minim Invasive Gynecol; 2015; 22(3):373-7. PubMed ID: 23850516
[TBL] [Abstract][Full Text] [Related]
14. Tumor markers in endometriosis.
Abrão MS; Podgaec S; Pinotti JA; de Oliveira RM
Int J Gynaecol Obstet; 1999 Jul; 66(1):19-22. PubMed ID: 10458545
[TBL] [Abstract][Full Text] [Related]
15. Correlation of preoperative biomarkers with severity of adhesion in endometriosis.
Lee Y; Lee Y; Lee S; Jung S; Chon S
J Gynecol Obstet Hum Reprod; 2020 Jan; 49(1):101637. PubMed ID: 31520750
[TBL] [Abstract][Full Text] [Related]
16. Panel of Autoimmune Markers for Noninvasive Diagnosis of Minimal-Mild Endometriosis.
Gajbhiye R; Bendigeri T; Ghuge A; Bhusane K; Begum S; Warty N; Sawant R; Padte K; Humane A; Dasmahapatra P; Chauhan A; Khan S
Reprod Sci; 2017 Mar; 24(3):413-420. PubMed ID: 27485360
[TBL] [Abstract][Full Text] [Related]
17. Elevated glycodelin-A concentrations in serum and peritoneal fluid of women with ovarian endometriosis.
Kocbek V; Vouk K; Mueller MD; Rižner TL; Bersinger NA
Gynecol Endocrinol; 2013 May; 29(5):455-9. PubMed ID: 23461865
[TBL] [Abstract][Full Text] [Related]
18. Increased serum cancer antigen-125 is a marker for severity of deep endometriosis.
Santulli P; Streuli I; Melonio I; Marcellin L; M'Baye M; Bititi A; Borghese B; Lafay Pillet MC; Chapron C
J Minim Invasive Gynecol; 2015 Feb; 22(2):275-84. PubMed ID: 25446542
[TBL] [Abstract][Full Text] [Related]
19. Comparative study between VEGF-A and CA-125 in diagnosis and follow-up of advanced endometriosis after conservative laparoscopic surgery.
Mohamed ML; El Behery MM; Mansour SA
Arch Gynecol Obstet; 2013 Jan; 287(1):77-82. PubMed ID: 22930151
[TBL] [Abstract][Full Text] [Related]
20. Soluble ICAM-1 levels in the serum of endometriotic patients appear to be independent of medical treatment.
Matalliotakis IM; Vassiliadis S; Goumenou AG; Athanassakis I; Koumantakis GE; Neonaki MA; Koumantakis EE
J Reprod Immunol; 2001 Jul; 51(1):9-19. PubMed ID: 11438377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
